July 31, 2009

Byrd Scores Additional Funds For Medical Research at Marshall University

The $3 million included in the funding measure by Byrd is for the continued development of a new Center for Diagnostic Nanosystems as part of Marshall University’s focus on emerging biotechnology and science programs. The center will be responsible for the development of new non-invasive nanotechnologies designed to detect and diagnose disease and illnesses at very early stages. Diseases that disproportionately impact rural populations, such as ovarian cancer, heart disease, and diabetes, many of which are common throughout the populations of West Virginia, will be the focus of this initial research.  The new program will be housed in the Robert C. Byrd Biotechnology Science Center.

“Early and faster discovery and diagnosis of these diseases is extremely important,” said Byrd.  “The research that is being conducted at Marshall University will not only help the citizens of West Virginia, but also for patients all across the country. So I am proud to be able to secure funding for this purpose.  The likelihood of prevention or successful treatment can hinge on early detection, and this program will help ensure that more West Virginians are treated successfully.

"Once again, Senator Byrd has generously demonstrated his support of Marshall University and the cutting-edge research being done at our Robert C. Byrd Biotechnology Center," said Marshall University President Stephen J. Kopp. "This new center will be a vital weapon in the fight against some of the most devastating diseases we face not only in West Virginia but across the country and around the world. We are exceedingly grateful for this funding and look forward to continuing to work with the Senator to better the lives of all West Virginians."

            The bill approved by the Senate must now be reconciled with the House –passed FY 2010 Energy and Water Development Appropriations bill before being sent to President Obama for his signature.

###

back